Document Detail


Arachidonate raises vascular resistance but not permeability in lungs of awake sheep.
MedLine Citation:
PMID:  7380683     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prostaglandins have been implicated as mediators of pulmonary hypertension in a variety of reactions, but the agents responsible for pathological increases in lung vascular permeability have not been determined. To test the hypothesis that products of arachidonic acid metabolism produce pulmonary vasoconstriction and alter lung vascular permeability, we infused purified sodium arachidonate (25-100 micrograms . kg-1 . min-1) into chronically instrumented unanesthetized sheep prepared for collection of lung lymph. Arachidonate produced dose-related increases in pulmonary artery pressure and lung lymph flow with corresponding decreases in the lymph-to-plasma protein concentration ratio. Lung lymph responses were like those caused by mechanically elevating left atrial pressure. Infusion of indomethacin or sodium eicosatetraynoate inhibited hemodynamic and lung lymph responses to arachidonate. We conclude a) that arachidonate must be converted to prostaglandin cyclic endoperoxides to produce pulmonary hypertension and increased flow of protein-poor lung lymph and b) that under normal conditions, no detectable increase in lung vascular permeability results from either arachidonate itself or the combined products of arachidonate metabolism via cyclooxygenase and/or lipoxygenase.
Authors:
M L Ogletree; K L Brigham
Related Documents :
3578553 - Angiotensin ii infusion increases thoracic duct lymph flow in chronically catheterized ...
4430713 - Increased sheep lung vascular permeability caused by pseudomonas bacteremia.
4014453 - In vivo membrane potentials of smooth muscle cells in the caudal artery of the rat.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of applied physiology: respiratory, environmental and exercise physiology     Volume:  48     ISSN:  0161-7567     ISO Abbreviation:  J Appl Physiol Respir Environ Exerc Physiol     Publication Date:  1980 Apr 
Date Detail:
Created Date:  1980-08-15     Completed Date:  1980-08-15     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  7801242     Medline TA:  J Appl Physiol Respir Environ Exerc Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  581-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arachidonic Acids / metabolism,  pharmacology*
Blood Pressure / drug effects
Capillary Permeability / drug effects*
Dose-Response Relationship, Drug
Indomethacin / pharmacology
Lung / blood supply*,  metabolism
Pulmonary Artery
Sheep / physiology
Vasomotor System / drug effects*
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The thoracic surgical treatment of tracheal stenoses (author's transl)
Next Document:  Effects of hypoxia on respiratory control in neonates at high altitude.